How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers
Katerina Chatzidionysiou, Bénédicte Delcoigne, Thomas Frisell, Merete Lund Hetland, Bente Glintborg, Lene Dreyer, René Cordtz, Kristian Zobbe, Dan Nordström, Nina Trokovic, Kalle Aaltonen, Sella Aarrestad Provan, Gerður Gröndal, Björn Guðbjörnsson, Johan Askling
Abstract
What is already known about this subject?
Topics & Concepts
MedicineMalignancyRheumatoid arthritisRituximabInternal medicinePopulationClinical PracticeOncologyPhysical therapyLymphomaEnvironmental healthChronic Lymphocytic Leukemia ResearchRheumatoid Arthritis Research and TherapiesLymphoma Diagnosis and Treatment